Abstract
A simple, rapid and sensitive HPLC method has been developed and validated for the analysis of letrozole in human plasma. The separation was achieved on a monolithic silica column using acetonitrile–phosphate buffer. A fluorescence detector was used for the quantitation with excitation and emission wavelengths at 230 and 295 nm. The assay enables the measurement of letrozole for therapeutic drug monitoring with a minimum quantification limit (LOQ) of 0.5 ng mL−1. The method involves a simple, one-step extraction procedure with complete recovery. Calibration was linear over the concentration range 0.5–80 ng mL−1. The coefficients of variation for inter-day and intra-day assay were found to be less than 8%.
Similar content being viewed by others
References
Lamb HM, Adkins JC (1998) Drugs 56:1125–1140
Iveson TJ, Smith IE, Ahern J, Smithers DA, Trunet PF, Dowsett M (1993) J Clin Endocrinol Metab 77:324–331
Pfister CU, Duval M, Godbillon J, Gosset G, Gygax D, Marfil F, Siouffi A, Winkler B (1994) J Pharm Sci 83:520–524
Marfil F, Pineau V, Siouffi A, Godbillon SJ (1993) J Chromatogr B 683:251–258
Siouffi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM, Godbillon SJ, Czendlik C, Howald H, Pfister CU, Vreeland F (1997) Biopharm Drug Dispos 18:779–789
Trosken ER, Fischer K, Volkel W, Lutz WK (2006) Toxicology 219:33–40
Dyderski S, Grzeskowiak E, Szalek E, Szkutnik D, Dubai V, Drobnik L (2005) Arzneimittelforschung 55:514–519
Acknowledgment
This work was supported by Noor Research and Educational Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zarghi, A., Foroutan, S.M., Shafaati, A. et al. HPLC Determination of Letrozole in Plasma Using Fluorescence Detection: Application to Pharmacokinetic Studies. Chroma 66, 747–750 (2007). https://doi.org/10.1365/s10337-007-0381-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-007-0381-9